Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

Jakob Schroder,Janus Christian Jakobsen,Per Winkel,Jørgen Hilden,Gorm Boje Jensen,Ahmad Sajadieh,Anders Larsson,Johan Ärnlöv,Marina Harutyunyan,Julia S. Johansen,Erik Kjøller,Christian Gluud,Jens Kastrup

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease

2020

Jakob Schroder
Janus Christian Jakobsen
Per Winkel
Jørgen Hilden
Gorm Boje Jensen
Ahmad Sajadieh
Anders Larsson
Johan Ärnlöv
Marina Harutyunyan
Julia S. Johansen
Erik Kjøller
Christian Gluud
Jens Kastrup

Background The inflammatory biomarker YKL‐40 has previously been studied as a potential risk marker in cardiovascular disease. We aimed to assess the prognostic reclassification potential of serum ...

Keywords:

Disease
Biomarker (medicine)
potential risk
Internal medicine
Cardiology
Medicine
Cohort study
coronary atherosclerosis
Coronary artery disease
CHI3L1
Diabetes mellitus
Unstable angina
Stroke
Myocardial infarction
Population study
Hazard ratio

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations